Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid

Thromb Res. 2020 Aug:192:2. doi: 10.1016/j.thromres.2020.05.001. Epub 2020 May 5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Factor VIII
  • Humans
  • Infections*
  • Macrophage Activation
  • Pandemics
  • Plasma Exchange
  • Pneumonia, Viral
  • SARS-CoV-2
  • von Willebrand Diseases*
  • von Willebrand Factor

Substances

  • von Willebrand Factor
  • Factor VIII